Perospirone Inhibits Kv1.5 in Coronary Smooth Muscle
2026-09-01
A 2025 Journal of Applied Toxicology study identifies a previously unrecognized vascular ion-channel action of perospirone: concentration-dependent, use-independent inhibition of Kv currents in freshly isolated rabbit coronary arterial smooth muscle cells. The findings extend the antipsychotic drug mechanism beyond serotonergic and dopaminergic signaling pathways and provide a focused basis for investigating possible cardiovascular effects.
FITC-Concanavalin A (ConA) Conjugate Guide
2026-08-31
FITC-Concanavalin A (ConA) Conjugate, SKU K4413, provides fluorescence-based detection of accessible α-D-glucose and α-D-mannose residues on glycoproteins and glycolipids. It is suited to cell surface carbohydrate detection, immunofluorescence staining, tissue labeling, and flow cytometry, but not to non-carbohydrate targets or use outside the specified storage conditions.
Melittin and the GPCR Logic of Glioblastoma
2026-08-30
A translational framework for using Melittin, a bioactive peptide and signal transduction modulator, to interrogate the Gs/Gi–PI3K-Akt axis alongside the miR-18a/ALOXE3 ferroptosis and migration circuitry identified in glioblastoma.
Sphingosine-1-phosphate: Assays & Workflows
2026-08-29
Sphingosine-1-phosphate enables controlled studies of receptor signaling, endothelial behavior, and context-dependent apoptosis. This workflow-focused guide connects rapid S1PR signaling assays with vascular and neuronal models while emphasizing fresh preparation, matched controls, and receptor-aware interpretation.
FGFR3 Inhibition in SLC26A2 Chondrodysplasia
2026-08-29
This study combines genetic models, chondrocyte assays, and pharmacological intervention to show that excessive FGFR3 signaling contributes to SLC26A2-related chondrodysplasia in mice. Its results support FGFR3 pathway inhibition as a mechanistically grounded, preclinical strategy for improving chondrocyte differentiation and skeletal microarchitecture.
MK-4827 (Niraparib): From Mechanism to Translation
2026-08-28
A translational perspective on MK-4827 (Niraparib), connecting selective PARP-1/-2 inhibition with BRCA-dependent vulnerability, hyperthermia-induced PARPi sensitization, and more rigorous cancer research strategies.
Standardized Whole-Blood Stimulation in Immunometabolism
2026-08-28
Zhao and colleagues present a standardized whole-blood stimulation protocol for measuring how metabolic interventions reshape immune-cell cytokine responses. The workflow preserves a complex human blood environment while introducing controlled immune stimuli and metabolic inhibitors, making it useful for cohort studies and mechanistic immunometabolism research.
Intravesical p21 mRNA-LNP Therapy for Bladder Cancer
2026-08-27
The reference study develops a nonviral strategy that delivers chemically modified CDKN1A/p21 mRNA in lipid nanoparticles directly into bladder tumors. Its findings show localized p21 restoration, cell-cycle disruption, DNA-damage signaling, apoptosis, and tumor suppression in an orthotopic mouse model, while highlighting the translational advantages and remaining limits of intravesical mRNA therapy.
Ginsenoside Rg1: From Mechanism to Translation
2026-08-27
A translational framework for using Ginsenoside Rg1 to investigate Treg-dependent gut-immune-brain signaling, neuroprotection, inflammation, and experimental reproducibility beyond conventional product-page claims.
Carbapenemase Gene Transfer in CREC Across Guangdong
2026-08-26
This 2025 BMC Microbiology study integrates gene localization, antimicrobial susceptibility, conjugation, mobile-element profiling, and strain typing to examine carbapenemase transmission in carbapenem-resistant Enterobacter cloacae. Its findings highlight plasmid-associated blaNDM-1, extensive multidrug resistance, and substantial horizontal-transfer potential across eight teaching hospitals in Guangdong.
N1-Methylpseudouridine in CRISPRa mRNA Workflows
2026-08-26
Learn how N1-Methylpseudouridine can support higher protein output from transient CRISPRa mRNA delivery while preserving rigorous splice-readout controls. This workflow-focused guide covers material handling, assay design, comparator selection, and troubleshooting for research laboratories.
TNF-alpha Recombinant Murine Protein Workflows
2026-08-25
Build reproducible apoptosis, inflammation, and receptor-signaling assays with a defined trimeric cytokine rather than relying on poorly controlled inflammatory stimuli. This guide combines practical dosing, storage, controls, and mechanistic comparisons with the latest evidence that RNA Pol II loss can trigger apoptosis through active signaling.
LRRC8A–CAV1 Signaling Drives PDAC Growth
2026-08-25
The reference study identifies a cholesterol-dependent LRRC8A–CAV1 membrane axis that links volume regulation with KRAS/EGFR signaling, ribosome biogenesis, protein synthesis, and pancreatic ductal adenocarcinoma growth. Its combined genetic, pharmacological, proteomic, xenograft, and organoid evidence provides a useful framework for studying how membrane organization supports biosynthetic expansion.
MMP-2-Responsive Liposomes for Breast Cancer Immunotherapy
2026-08-24
The reference study developed a cascade-targeted liposome that sequentially delivers the PD-1 pathway-blocking peptide AUNP-12 and the IDO inhibitor NLG919. By coupling MMP-2-responsive release with secondary tumor-cell targeting, the platform remodeled an immunosuppressive breast cancer microenvironment and improved antitumor immune responses.
EZ Cap™ Cy5 EGFP mRNA (5-moUTP) Workflow
2026-08-23
Build a dual-channel workflow that separates mRNA uptake from productive translation in the same cells. EZ Cap™ Cy5 EGFP mRNA (5-moUTP) supports nanoparticle screening, macrophage delivery studies, and quantitative transfection optimization with direct Cy5 tracking and EGFP functional readout.
479 records 8/32 page Previous Next First page 上5页 678910 下5页 Last page